A 3′UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1

Polymorphisms within theCOL5A13′-UTR That Alters mRNA Structure and theMIR608Gene are Associated with Achilles Tendinopathy

(2013) Yoonus Abrahams et al.   ANNALS OF HUMAN GENETICS

DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

(2013) J. Cao et al.   CANCER RESEARCH

The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival

(2013) R. Wang et al.   Clinical & Translational Oncology

Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective

(2013) Marc Maliepaard et al.   NATURE REVIEWS DRUG DISCOVERY

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1

(2012) Jing Liu et al.   BMC CANCER

RNA-Based Therapeutics: Current Progress and Future Prospects

(2012) John C. Burnett et al.   CHEMISTRY & BIOLOGY

Polo-Like Kinases Inhibitors

(2012) L. Garuti et al.   CURRENT MEDICINAL CHEMISTRY

miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours

(2012) Francesca Biagioni et al.   EMBO Molecular Medicine

The centrosome as potential target for cancer therapy and prevention

(2012) Nina Korzeniewski et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Kinetic analysis of the effects of target structure on siRNA efficiency

(2012) Jiawen Chen et al.   JOURNAL OF CHEMICAL PHYSICS

Dissecting the phenotypes of Plk1 inhibition in cancer cells using novel kinase inhibitory chemical CBB2001

(2012) Rongfeng Lan et al.   LABORATORY INVESTIGATION

MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genes

(2012) Jie He et al.   NUCLEIC ACIDS RESEARCH

Unraveling the Regulatory Mechanisms Underlying Tissue-Dependent Genetic Variation of Gene Expression

(2012) Jingyuan Fu et al.   PLoS Genetics

Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions

(2011) Leonidas Benetatos et al.   ANNALS OF HEMATOLOGY

Intravenous liposomal delivery of the short hairpin RNAs against Plk1 controls the growth of established human hepatocellular carcinoma

(2011) Hongxin Deng et al.   CANCER BIOLOGY & THERAPY

Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian Cancer

(2011) N. Syed et al.   CANCER RESEARCH

Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy

(2011) Ivan Bièche et al.   Molecular Cancer

Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer

(2010) Tetsuo Ito et al.   INTERNATIONAL JOURNAL OF CANCER

PLK1 Phosphorylates Mitotic Centromere-associated Kinesin and Promotes Its Depolymerase Activity

(2010) Liangyu Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression profiling of G2/M phase regulatory proteins in normal, premalignant and malignant uterine cervix and their correlation with survival of patients

(2010) Chhavi et al.   Journal of Cancer Research and Therapeutics

H2A.Z Maintenance during Mitosis Reveals Nucleosome Shifting on Mitotically Silenced Genes

(2010) Theresa K. Kelly et al.   MOLECULAR CELL

A map of human genome variation from population-scale sequencing

(2010) Richard M. Durbin et al.   NATURE

Predicting in vivo binding sites of RNA-binding proteins using mRNA secondary structure

(2010) X. Li et al.   RNA

Bladder cancer SNP panel predicts susceptibility and survival

(2009) Angeline S. Andrew et al.   HUMAN GENETICS

Polo-like Kinase 1 (PLK1) Regulates Interferon (IFN) Induction by MAVS

(2009) Damien Vitour et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy

(2009) Yingmei Wang et al.   Molecular Cancer

Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients

(2009) Zi-Li He et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Eukaryotic transcription factor binding sites--modeling and integrative search methods

(2008) S. Hannenhalli   BIOINFORMATICS

Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: Current and developing technologies

(2008) B CHORLEY et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH